The pharmacokinetics of lopinavir/ritonavir in combination with atazanavir in HIV-infected subjects

Trial Profile

The pharmacokinetics of lopinavir/ritonavir in combination with atazanavir in HIV-infected subjects

Suspended
Phase of Trial: Phase IV

Latest Information Update: 04 Jan 2013

At a glance

  • Drugs Atazanavir; Lopinavir/ritonavir
  • Indications HIV infections
  • Focus Pharmacokinetics
  • Most Recent Events

    • 23 Apr 2008 The expected completion date for this trial is now 1 Jun 2008.
    • 23 Apr 2008 Status changed from recuiting to suspended.
    • 08 Feb 2007 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top